DR
David Risinger Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
5.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $60 |
9%
upside
| 1 | -0.91% |
0
%
| 13 Jan ‘26 5 days ago |
|
|
|
Outperform
Maintained
| $525 |
19%
upside
| 1 | +9.1% |
0
%
| 29 Dec ‘25 20 days ago |
|
|
|
Outperform
Maintained
| $32 |
38%
upside
| 1 | +25% |
0
%
| 15 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $45 |
71%
upside
| 1 | -23% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $1,104 |
6%
upside
| 1 | +12% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Outperform
Initiated
| $30 |
359%
upside
| 1 | -12% |
0
%
| 24 Oct ‘25 2 months ago |
|